Følg
Ingrid Quist-Løkken
Ingrid Quist-Løkken
Medical Research Student, NTNU
Verifisert e-postadresse på stud.ntnu.no
Tittel
Sitert av
Sitert av
År
Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3. 1] aza-amides
JM Kolos, S Pomplun, S Jung, B Rieß, PL Purder, AM Voll, S Merz, ...
Chemical science 12 (44), 14758-14765, 2021
232021
High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells
C Andersson-Rusch, B Liu, I Quist-Løkken, PD Upton, OE Olsen, H Hella, ...
Scientific Reports 13 (1), 6639, 2023
22023
FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells
I Quist-Løkken, C Andersson-Rusch, MH Kastnes, JM Kolos, J Jatzlau, ...
Cell Communication and Signaling 21 (1), 25, 2023
22023
Classification of Breast Cancer Based on DCE MRI
IQ Løkken
NTNU, 2017
12017
Genome-Wide CRISPR/Cas9 Knock-out Screen Identifies Apoptosis-Relevant Genes in Multiple Myeloma
CL Andersson-Rusch, I Quist-Løkken, P Sætrom, V Beisvåg, M Rolinski, ...
Blood 142, 4660, 2023
2023
Targeting FKBP12 enables bone morphogenetic proteins to kill multiple myeloma cells via ALK2
I Quist-Løkken, C Andersson-Rusch, MH Kastnes, JM Kolos, J Jatzlau, ...
2023
Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3. 1] aza-amides
PL Purder, AM Voll, S Merz, M Gnatzy, TM Geiger, I Quist-Løkken, ...
2021
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–7